Effects of a Multidisciplinary Integrated Care Model on Care Outcomes in Patients With Heart Failure With Preserved Ejection Fraction
NCT07798856 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2026-09-01
Summary
Heart failure with preserved ejection fraction (HFpEF) accounts for approximately half of all heart failure cases and is associated with frequent hospitalizations, poor quality of life, and limited effective treatment options. Fragmented, single-discipline care often fails to address the multiple comorbidities and self-management needs of this population.
This study evaluates a Multidisciplinary Integrated Care Model (MICM) for patients with HFpEF, delivered by a coordinated team including cardiologists, case managers, pharmacists, dietitians, and rehabilitation specialists. The intervention group will receive structured team-based care, including regular follow-up, medication optimization, dietary and lifestyle counseling, and exercise guidance, in addition to standard cardiology care.
Using a prospective quasi-experimental design with a historical control group, this study compares clinical and patient-reported outcomes between patients receiving the multidisciplinary integrated care model and a historical cohort receiving usual care. The primary aim is to determine whether this integrated care approach improves outcomes such as heart failure-related hospitalization, functional status, and quality of life in patients with HFpEF.
Conditions
- Heart Failure With Preserved Ejection Fraction (HFpEF)
- Heart Failure
Interventions
- OTHER
-
Multidisciplinary Integrated Care Model (MICM)
A structured, team-based care program integrating cardiology management, case management, pharmacist-led medication review, nutritional counseling, and exercise guidance, delivered to patients with heart failure with preserved ejection fraction.
- OTHER
-
Usual Care
Standard, non-integrated cardiology care as routinely provided prior to implementation of the multidisciplinary integrated care model.
Sponsors & Collaborators
-
Chimei Medical Center
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-08-31
- Primary Completion
- 2027-07-31
- Completion
- 2027-10-31
Countries
- Taiwan
Study Locations
More Related Trials
-
The Gut Microbiota and Metabolites in HFpEF
NCT06645535 ·Status: ENROLLING_BY_INVITATION
-
Staging Heart Failure With Preserved Ejection Fraction
NCT06931015 ·Status: NOT_YET_RECRUITING
-
Outcome of Discharged HFmrEF Patients
NCT05240118 ·Status: COMPLETED
-
Digital Remote Management Versus Usual Care for Optimization of Guideline-directed Medical Therapy in Patients With Heart Failure and Reduced Ejection Fraction: a Multicentre, Randomised, Controlled Trial (DigiCare-HFrEF)
NCT07352891 ·Status: RECRUITING ·Phase: NA
-
Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction
NCT06114498 ·Status: ACTIVE_NOT_RECRUITING
-
Understanding and Treating Heart Failure With Preserved Ejection Fraction: Novel Mechanisms, Diagnostics and Potential Therapeutics
NCT02052804 ·Status: COMPLETED
-
Cardiometabolic evalUation REgistry of Heart Failure
NCT06939985 ·Status: RECRUITING
-
The Relationship Between Epicardial Fat Tissue and Cardiac Function in HFpEF Patients
NCT05068934 ·Status: COMPLETED
-
Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction
NCT06517186 ·Status: RECRUITING
-
Association Between Coronary and Peripheral Vascular Injury in Heart Failure Patients With Preserved Ejection Fraction.
NCT05884346 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Xinyue Capsule in the Treatment of Heart Failure With Preserved Ejection Fraction
NCT06946095 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Prognostic Impact of Noncardiac Comorbidities in Heart Failure Patients
NCT02946476 ·Status: COMPLETED
-
Prospective Study of Heart Failure With Preserved Left Ventricular Ejection Fraction
NCT01091467 ·Status: COMPLETED
-
Retrospective Observational Analysis of a Cohort With Heart Failure With Preserved Ejection Fraction
NCT04233086 ·Status: COMPLETED
-
Hospital-Community-Family-Care Management Platform for Chronic Heart Failure
NCT02029287 ·Status: UNKNOWN ·Phase: NA
-
The Use of Advanced Imaging in HFpEF
NCT06905405 ·Status: RECRUITING
-
Cohort Study of Chronic Heart Failure
NCT05960890 ·Status: RECRUITING ·Phase: NA
-
Heart Failure Evaluation Study
NCT05583513 ·Status: COMPLETED
-
Isometric Exercise Training in Participants With Heart Failure With Preserved Ejection Fraction
NCT05551663 ·Status: UNKNOWN ·Phase: NA
-
Heart Failure Center Accreditation in China (HF-CAP Trial)
NCT07371780 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Timely Interventions to Enable and Reach Patients With Heart Failure, and Their Caregivers With Palliative Care
NCT06244953 ·Status: RECRUITING ·Phase: NA
-
DevElopMent of Clinical PATHwaYs to the Diagnosis of Heart Failure With Preserved Ejection Fraction
NCT05792059 ·Status: UNKNOWN
-
Semaphorins 3A and 4D Levels in Heart Failure Patients
NCT02406716 ·Status: UNKNOWN
-
The Heart Failure With Preserved Ejection Fraction (HFpEF) Pathophysiology Study.
NCT03186833 ·Status: COMPLETED
-
Chemoreflex Sensitivity in HFpEF
NCT06309537 ·Status: NOT_YET_RECRUITING